The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Effect of Dipyridamole plus Aspirin on Hemodialysis Graft Patency
Open accessAbstract
BACKGROUND: Arteriovenous graft stenosis leading to thrombosis is a major cause of complications in patients undergoing hemodialysis. Procedural interventions may restore patency but are costly. Although there is no proven pharmacologic therapy, dipyridamole may be promising because of its known vascular antiproliferative activity. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of extended-release dipyridamole, at a dose of 200 mg, and aspirin, at a dose of 25 mg, given twice daily after the placement of a new arteriovenous graft until the primary outcome, loss of primary unassisted patency (i.e., patency without thrombosis or requirement for intervention), was reached. Secondary outcomes were cumulative graft failure and death. Primary and secondary outcomes were analyzed with the use of a Cox proportional-hazards regression with adjustment for prespecified covariates. RESULTS: At 13 centers in the United States, 649 patients were randomly assigned to receive dipyridamole plus aspirin (321 patients) or placebo (328 patients) over a period of 4.5 years, with 6 additional months of follow-up. The incidence of primary unassisted patency at 1 year was 23% (95% confidence interval [CI], 18 to 28) in the placebo group and 28% (95% CI, 23 to 34) in the dipyridamole-aspirin group, an absolute difference of 5 percentage points. Treatment with dipyridamole plus aspirin significantly prolonged the duration of primary unassisted patency (hazard ratio, 0.82; 95% CI, 0.68 to 0.98; P=0.03) and inhibited stenosis. The incidences of cumulative graft failure, death, the composite of graft failure or death, and serious adverse events (including bleeding) did not differ significantly between study groups. CONCLUSIONS: Treatment with dipyridamole plus aspirin had a significant but modest effect in reducing the risk of stenosis and improving the duration of primary unassisted patency of newly created grafts. (ClinicalTrials.gov number, NCT00067119.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,882
Self-citationDiener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00308-5 · Cited by 1,577
Forbes, C., & Collaborators, E. (1997) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1997.tb11433.x · Cited by 1,411
Dember, L. M., Beck, G. J., Allon, M., Delmez, J. A., Dixon, B. S., Greenberg, A., Himmelfarb, J., Vazquez, M. A., Gassman, J. J., Greene, T., et al. (2008) · JAMA · doi:10.1001/jama.299.18.2164 · Cited by 826
Self-citationHemodialysis vascular access morbidity.
Feldman, H. I., Kobrin, S., & Wasserstein, A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v74523 · Cited by 667
Self-citationHemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint
Roy-Chaudhury, P., Sukhatme, V. P., & Cheung, A. K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050615 · Cited by 584
Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations
Chesebro, J. H., Fuster, V., Elveback, L. R., Clements, I. P., Smith, H. C., Holmes, D. R., Bardsley, W. T., Pluth, J. R., Wallace, R. B., Puga, F. J., et al. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401263100401 · Cited by 516
Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
Wang, S. K., & Tsiatis, A. A. (1987) · Biometrics · doi:10.2307/2531959 · Cited by 341
Xue, J. L., Dahl, D., Ebben, J. P., & Collins, A. J. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.004 · Cited by 338
Gibson, K. D., Gillen, D. L., Caps, M. T., Kohler, T. R., Sherrard, D. J., & Stehman-Breen, C. O. (2001) · Journal of Vascular Surgery · doi:10.1067/mva.2001.117890 · Cited by 319
Current Management of Vascular Access
Allon, M. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00860207 · Cited by 289
Self-citationVascular access survival among incident hemodialysis patients in the United States
Woods, J. D., Turenne, M. N., Strawderman, R. L., Young, E. W., Hirth, R. A., Port, F. K., & Held, P. J. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90564-3 · Cited by 260
Hess, H., Mietaschk, A., & Deichsel, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91144-4 · Cited by 258
Kaufman, J. S., O’Connor, T. Z., Zhang, J. H., Cronin, R. E., Fiore, L. D., Ganz, M. B., Goldfarb, D. S., & Peduzzi, P. N. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000081661.10246.33 · Cited by 237
Self-citationAnti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study
Sreedhara, R., Himmelfarb, J., Lazarus, J. M., & Hakim, R. M. (1994) · Kidney International · doi:10.1038/ki.1994.192 · Cited by 211
Self-citationNatural history of arteriovenous grafts in hemodialysis patients
Miller, P. E., Carlton, D., Deierhoi, M. H., Redden, D. T., & Allon, M. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8269 · Cited by 205
Self-citationCrowther, M. A., Clase, C. M., Margetts, P. J., Julian, J., Lambert, K., Sneath, D., Nagai, R., Wilson, S., & Ingram, A. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000027356.16598.99 · Cited by 186
Saran, R., Dykstra, D. M., Wolfe, R. A., Gillespie, B., Held, P. J., & Young, E. W. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36895 · Cited by 176
National Profile of Practice Patterns for Hemodialysis Vascular Access in the United States
Reddan, D. N., Klassen, P., Frankenfield, D. L., Szczech, L. A. M., Schwab, S., Coladonato, J. A., Rocco, M., Lowrie, E. G., & Owen, W. F. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022422.79790.a8 · Cited by 124
Adenosine Inhibits Growth of Human Aortic Smooth Muscle Cells Via A2BReceptors
Dubey, R. K., Gillespie, D. G., Mi, Z., et al. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.516 · Cited by 98
Dörffler-Melly, J., Koopman, M. M. W., Prins, M. H., & Buller, H. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002071.pub2 · Cited by 83
Singh, J. P., Rothfuss, K. J., Wiernicki, T. R., Lacefield, W. B., Kurtz, L. E., Brown, R. F., Brune, K. A., Bailey, D. L., & Dubé, G. P. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90752-8 · Cited by 51
Chronic Kidney Disease and the Public Health
Himmelfarb, J. (2007) · JAMA · doi:10.1001/jama.297.23.2630 · Cited by 49
Self-citationDesign of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial
Dixon, B. S., Beck, G. J., Dember, L. M., Depner, T. A., Gassman, J., Greene, T., Himmelfar, J., Hunsicker, L. G., Kaufman, J. S., Lawson, J. H., et al. (2005) · Clinical Trials · doi:10.1191/1740774505cn110oa · Cited by 31
Self-citationModel system to study interaction of platelets with damaged arterial wall
Ingerman-Wojenski, C. M., & Silver, M. J. (1988) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(88)90050-0 · Cited by 26
Cited by
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Self-citationPurinergic Signaling during Inflammation
Eltzschig, H. K., Sitkovsky, M. V., & Robson, S. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205750 · Cited by 706
Purinergic Signaling during Inflammation
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1300259 · Cited by 608
Stent Graft versus Balloon Angioplasty for Failing Dialysis-Access Grafts
Haskal, Z. J., Trerotola, S., Dolmatch, B., Schuman, E., Altman, S., Mietling, S., Berman, S., McLennan, G., Trimmer, C., Ross, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902045 · Cited by 422
Lawson, J. H., Glickman, M. H., Ilzecki, M., Jakimowicz, T., Jaroszynski, A., Peden, E. K., Pilgrim, A. J., Prichard, H. L., Guziewicz, M., Przywara, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00557-2 · Cited by 381
Self-citation
Metadata
- Authors
- Dixon, B. S., Beck, G. J., Vazquez, M. A., Greenberg, A., Delmez, J. A., Allon, M., Dember, L. M., Himmelfarb, J., Gassman, J. J., Greene, T., Radeva, M. K., Davidson, I. J., Ikizler, T. A., Braden, G. L., Fenves, A. Z., Kaufman, J. S., Cotton, J. R., Martin, K. J., McNeil, J. W., Rahman, A., Lawson, J. H., Whiting, J. F., Hu, B., Meyers, C. M., Kusek, J. W., & Feldman, H. I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-05-21
- Volume
- 360
- Issue
- 21
- Pages
- 2191-2201
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2147768294
- Cited by
- 290
- References
- 26
- FWCI
- 43.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.